These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1803 related articles for article (PubMed ID: 24333401)
1. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
2. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail. Vitorino C; Almeida J; Gonçalves LM; Almeida AJ; Sousa JJ; Pais AA J Control Release; 2013 May; 167(3):301-14. PubMed ID: 23454133 [TBL] [Abstract][Full Text] [Related]
3. Expanding Transdermal Delivery with Lipid Nanoparticles: A New Drug-in-NLC-in-Adhesive Design. Mendes M; Nunes SCC; Sousa JJ; Pais AACC; Vitorino C Mol Pharm; 2017 Jun; 14(6):2099-2115. PubMed ID: 28475834 [TBL] [Abstract][Full Text] [Related]
4. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Baek JS; Pham CV; Myung CS; Cho CW Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Khurana S; Jain NK; Bedi PM Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071 [TBL] [Abstract][Full Text] [Related]
7. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation. Yang Z; Teng Y; Wang H; Hou H Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076 [TBL] [Abstract][Full Text] [Related]
9. Can lipid nanoparticles improve intestinal absorption? Mendes M; Soares HT; Arnaut LG; Sousa JJ; Pais AACC; Vitorino C Int J Pharm; 2016 Dec; 515(1-2):69-83. PubMed ID: 27667757 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. Fan X; Chen J; Shen Q Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313 [TBL] [Abstract][Full Text] [Related]
11. How can lipid nanocarriers improve transdermal delivery of olanzapine? Iqbal N; Vitorino C; Taylor KM Pharm Dev Technol; 2017 Jun; 22(4):587-596. PubMed ID: 27876425 [TBL] [Abstract][Full Text] [Related]
12. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne. Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703 [TBL] [Abstract][Full Text] [Related]
13. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Elnaggar YS; El-Massik MA; Abdallah OY Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508 [TBL] [Abstract][Full Text] [Related]
14. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation. Mennini N; Cirri M; Maestrelli F; Mura P Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863 [TBL] [Abstract][Full Text] [Related]
15. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development. Nagaich U; Gulati N Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874 [TBL] [Abstract][Full Text] [Related]
16. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies. Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361 [TBL] [Abstract][Full Text] [Related]
17. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin. Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487 [TBL] [Abstract][Full Text] [Related]
18. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system. Zhao X; Sun Y; Li Z Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919 [TBL] [Abstract][Full Text] [Related]
19. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556 [No Abstract] [Full Text] [Related]
20. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers. Wang W; Chen L; Huang X; Shao A AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]